Skip to main content Accessibility help
×
Home

C1 metabolism and CVD outcomes in older adults

  • Helene McNulty (a1), J. J. Strain (a1), Kristina Pentieva (a1) and Mary Ward (a1)

Abstract

CVD is the most common cause of death in people over 65 years. This review considers the latest evidence for a potential protective effect of C1 donors (folate and the metabolically related B-vitamins) in CVD. Such an effect may or may not be mediated via the role of these nutrients in maintaining plasma homocysteine concentrations within a desirable range. Despite predictions from epidemiological studies that lowering plasma homocysteine would reduce cardiovascular risk, several secondary prevention trials in at-risk patients published since 2004 have failed to demonstrate a benefit of homocysteine-lowering therapy with B-vitamins on CVD events generally. All these trials were performed in CVD patients with advanced disease; thus current evidence suggests that intervention with high-dose folic acid is of no benefit in preventing another event, at least in the case of heart disease. The evidence at this time, however, is stronger for stroke, with meta-analyses of randomised trials showing that folic acid reduces the risk of stroke, particularly in people with no history of stroke. Genetic studies provide convincing evidence to support a causal relationship between sub-optimal B-vitamin status and CVD. People homozygous for the common C677T variant in the gene encoding the folate-metabolising enzyme, methylenetetrahydrofolate reductase (MTHFR), typically have a 14–21% higher risk of CVD. Apart from folate, riboflavin is required as a co-factor for MTHFR. New evidence shows that riboflavin intervention results in marked lowering of blood pressure, specifically in patients with the MTHFR 677TT genotype. This novel gene–nutrient interaction may provide insights as to the mechanism that links C1 metabolism with CVD outcomes.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      C1 metabolism and CVD outcomes in older adults
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      C1 metabolism and CVD outcomes in older adults
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      C1 metabolism and CVD outcomes in older adults
      Available formats
      ×

Copyright

Corresponding author

*Corresponding author: Professor Helene McNulty, fax +44 28-70124965, email h.mcnulty@ulster.ac.uk

References

Hide All
1.Homocysteine Lowering Trialists' Collaboration (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-analysis of the randomized trials. Am J Clin Nutr 82, 806812.
2.Eussen, SJ, de Groot, LC, Clarke, R et al. (2005) Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: A dose-finding trial. Arch Intern Med 165, 11671172.
3.McKinley, MC, McNulty, H, McPartlin, J et al. (2001) Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 73, 759764.
4.McNulty, H, Dowey le, RC, Strain, JJ et al. (2006) Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation 113, 7480.
5.Strain, JJ, Dowey, L, Ward, M et al. . (2004) B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc 63, 597603.
6.The Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke. JAMA 288, 20152022.
7.Wald, DS, Law, M & Morris, JK (2002) Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 325, 12021208.
8.Yang, Q, Botto, LD, Erickson, JD et al. (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113, 13351343.
9.Toole, JF, Malinow, MR, Chambless, LE et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291, 565575.
10.Lonn, E, Yusuf, S, Arnold, MJ et al. (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354, 15671577.
11.Bønaa, KH, Njølstad, I, Ueland, PM et al. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354, 15781588.
12.Ebbing, M, Bleie, Ø, Ueland, PM et al. (2008) Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. JAMA 300, 795804.
13.Albert, CM, Cook, NR, Gaziano, JM et al. (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease. A randomized trial. JAMA 299, 20272036.
14.Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group (2010) Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors. JAMA 303, 24862494.
15.VITATOPS Trial Study Group (2010) B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: A randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 9, 855865.
16.B-Vitamin Treatment Trialists' Collaboration (2006) Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. Am Heart J 151, 282287.
17.Saposnik, G, Ray, JG, Sheridan, P et al. (2009) Homcysteine-lowering therapy and stroke risk, severity, and disability: Additional findings from the HOPE 2 trial. Stroke 40, 13651372.
18.Wang, X, Qin, X, Demirtas, H et al. (2007) Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 369, 18761882.
19.Lee, M, Hong, KS, Chang, SC et al. (2010) Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: A meta-analysis. Stroke 41, 12051212.
20.Frosst, P, Blom, HJ, Milos, R et al. (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111113.
21.Jacques, PF, Bostom, AG, Williams, RR et al. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 79.
22.Wilcken, B, Bamforth, F, Li, Z et al. (2003) Geographical and ethnic variation of the 677C→T allele of 5, 10 methylenetetrahydrofolate reductase (MTHFR): Findings from over 7000 newborns from 16 areas world wide. J Med Genet 40, 619625.
23.Klerk, M, Verhoef, P, Clarke, R et al. (2002) MTHFR C677T polymorphism and risk of coronary heart disease: A meta-analysis. JAMA 288, 20232031.
24.Lewis, SJ, Ebrahim, S & Davey-Smith, G (2005) Meta-analysis of the MTHFR 677C→T polymorphism and coronary heart disease: Does totality of evidence support causal role for homocysteine and preventative potential of folate. Br Med J 331, 10531059.
25.Holmes, MV, Newcombe, P, Hubacek, JA et al. (2011) Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: A meta-analysis of genetic studies and randomised trials. Lancet 378, 584594.
26.Wang, W, Lee, ET, Fabsitz, RR et al. (2006) A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: The Strong Heart Study. Hypertension 47, 403409.
27.Staessen, JA, Wang, JG & Thijs, L (2001) Cardiovascular protection and BP reduction: A meta-analysis. Lancet 358, 13051315.
28.Wilson, CP, McNulty, H, Scott, JM et al. (2010) The MTHFR C677T polymorphism, B-vitamins and blood pressure. Proc Nutr Soc 69, 156165.
29.Horigan, G, McNulty, H, Ward, M et al. (2010) Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the C677T polymorphism in MTHFR. J Hypertens 28, 478486.
30.Yamada, K, Chen, Z, Rozen, R et al. (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 98, 1485314858.
31.Antoniades, C, Shirodaria, C, Leeson, P et al. (2009) MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 119, 25072515.
32.McNulty, H & Scott, JM (2008) Intake and status of folate and related B-vitamins: Considerations and challenges in achieving optimal status. Br J Nutr 99, S48S54.
33.Hoey, L, McNulty, H, Askin, N et al. (2007) Impact of a voluntary food fortification policy on folate, related B-vitamin status and homocysteine in healthy adults. Am J Clin Nutr 86, 14051413.
34.McNulty, B, Pentieva, K, Marshall, B et al. (2011) Women's compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. Hum Reprod 26, 15301536.
35.Reynolds, E (2006) Vitamin B12, folic acid, and the nervous system. Lancet Neurol 5, 949960.
36.Morris, MS, Jacques, PF, Rosenberg, IH et al. (2007) Folate and vitamin B12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 85, 193200.
37.Kim, Y-I (1999) Folate and carcinogenesis: Evidence, mechanisms, and implications. J Nutr Biochem 10, 6688.
38.Ericson, U, Sonestedt, E, Gullberg, B et al. (2007) High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort. Am J Clin Nutr 86, 434443.
39.Gibson, TM, Weinstein, SJ, Pfeiffer, RM et al. (2011) Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am J Clin Nutr 94, 10531062.
40.Cole, BF, Baron, JA, Sandler, RS et al. (2007) Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA 297, 23512359.
41.Figueiredo, JC, Grau, MV, Haile, RW et al. (2009) Folic acid and risk of prostate cancer: Results from a randomized clinical trial. J Natl Cancer Inst 101, 432435.
42.Ebbing, M, Bønaa, KH, Nygård, O et al. (2009) Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 302, 21192126.
43.Mason, JB (2011) Folate consumption and cancer risk: A confirmation and some reassurance, but we're not out of the woods quite yet. Am J Clin Nutr 94, 965966.
44.Tighe, P, Ward, M, McNulty, H et al. (2011) A dose-finding trial of the effect of long-term folic acid intervention: Implications for food fortification policy. Am J Clin Nutr 93, 1118.
45.Malinow, MR, Bostom, AG & Krauss, RM (1999) Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99, 178182.
46.Hoey, L, Strain, JJ & McNulty, H (2009) Studies of biomarker responses to intervention with vitamin B-12: A systematic review of randomized controlled trials. Am J Clin Nutr 89, Suppl., 1981S1996S.
47.Clarke, R, Refsum, H, Birks, J et al. (2003) Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr 77, 12411247.
48.Carmel, R (1997) Cobalamin, the stomach, and aging. Am J Clin Nutr 66, 750759.
49.Institute of Medicine, Panel on Folate, Other B Vitamins, and Choline (1998) Dietary Reference Intake; Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press.
50.Ruston, D, Hoare, J, Henderson, L et al. (2004) The National Diet and Nutrition Survey: Adults Aged 19 to 64 Years. Vol. 4: Nutritional Status (Anthropometry and Blood Analytes), Blood Pressure and Physical Activity. London: The Stationery Office.

Keywords

C1 metabolism and CVD outcomes in older adults

  • Helene McNulty (a1), J. J. Strain (a1), Kristina Pentieva (a1) and Mary Ward (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed